AstraZeneca

US · AZN #55 by market cap Listed 1970 Quant Rating B 70

162.70 -2.07 -1.26%

Collector offline (last heartbeat: 19036s ago) · 2026-09-04 20:02

Pre-market 162.79 -1.20%

After-hours 163.00 +0.18%

Overnight 165.15 +0.23%

Market cap: 252.33B
P/E (TTM): 24.36
P/B: 5.02
EPS: 6.54
Div yield: 1.95%
52W pos: 29%

About AstraZeneca

AstraZeneca is a biopharmaceutical company focused on oncology, rare diseases, and a biopharmaceuticals group spanning cardiovascular, renal and metabolic disease and respiratory and immunology treatments. It traces to 1913 and is headquartered in Cambridge, England.

Founded: 1913
CEO: Mr. Pascal Soriot
Employees: 94,300
Headquarters: Cambridge, Cambridgeshire, United Kingdom of Great Britain and Northern Ireland (the)
Fiscal year end: 12-31
Website: astrazeneca.com

View SEC filings on EDGAR ›

Company profile

Exchange: US
Symbol: AZN
Market-cap rank: #55
Listing date: 1970-01-01
Market cap: 252.33B
Float cap: 251.02B
Shares out: 1.55B
Float shares: 1.54B

Sectors & themes

Infectious Disease Drug Manufacturers - General Fractional Shares JP

Browse all sectors & themes

Quote time 2026-09-04 20:02:24

For reference only, not investment advice.